Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
Public ClinicalTrials.gov record NCT00802100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparison of Optimal Antipsychotic Treatments for Schizophrenia Pilot Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare the safety and effectiveness of three different antipsychotic medications, as well as the use of other medications to limit treatment side effects, in adults with schizophrenia.
Study identification
- NCT ID
- NCT00802100
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 21 participants
Conditions and interventions
Conditions
Interventions
- Olanzapine Drug
- Perphenazine Drug
- Aripiprazole Drug
- Metformin Drug
- Simvastatin Drug
- Benztropine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2008 (Type not available)
- Primary completion
- Sep 2009 (Actual)
- Completion
- Oct 2009 (Actual)
- Last update posted
- Feb 8, 2013
2008 – 2009
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SHANTI Clinical Trials | Colton | California | 92324 | — |
| Stanford University | Palo Alto | California | 94305 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| University of Miami School of Medicine | Miami | Florida | 33316 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| Clinical Insights | Glen Burnie | Maryland | 21061 | — |
| University of Massachusetts | Worcester | Massachusetts | 01605 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| University of Minnesota School of Medicine | Minneapolis | Minnesota | 55454 | — |
| Research Foundation for Mental Hygiene | New York | New York | 10032 | — |
| Duke University Medical Center-John Umstead Hospital | Butner | North Carolina | 27509 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75235 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00802100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2013 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00802100 live on ClinicalTrials.gov.